Patent Assignment
Reel/Frame 019501/0284
Assignment of Assignor's Interest
Recorded: 2007-06-29
Pages: 3
Assignor
INFIGEN, INC.
Executed: 2007-02-01
Assignee
ADVANCED CELL TECHNOLOGY, INC.
11100 SANTA MONICA BLVD., SUITE 850, LOS ANGELES, CALIFORNIA, 90025
Covered Property
(1)
Ungulates Produced by Sequential Nuclear Transfer
Patent:
6,603,059 →
Application:
09/688,782 →
Related Assignments
(11)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Interest
Jun 3, 2002
From: HANCOCK LIFE INSURANCE COMPANY; INVESTORS PARTNER LIFE INSURANCE COMPANY; MASSACHUSETTS MUTUAL LIFE INSURANCE COMPANY; MASSMUTUAL CORPORATE VALUE PARTNERS, LTD.
To: INFIGEN, INC.
Reel/Frame 012954/0595 →
Security Agreement
Jun 6, 2002
From: INFIGEN, INC.
To: WISCONSIN DEPARTMENT OF COMMMERCE BUREAU OF BUSINESS FINANCE
Reel/Frame 012952/0849 →
Release of Security Interest
Sep 9, 2004
From: WISCONSIN DEPARTMENT OF COMMERCE
To: INFIGEN, INC.
Reel/Frame 015098/0332 →
Grant of a Security Interest in Grantor's (Debtor'
Feb 27, 2006
From: PHARMING GROUP N.V.
To: KING GEORGE HOLDINGS LUXEMBOURG IIA S.A.R.L.
Reel/Frame 017223/0001 →
License
Mar 2, 2006
From: INFIGEN, INC.
To: PHARMING GROUP N.V.
Reel/Frame 017240/0454 →
Corrective Assignment to Correct the Property Type: Patent Number 6630059 Previously Recorded on Reel 017223 Frame 0001. Assignor(S) Hereby Confirms the Grant of a Security Interest in Grantor's (Debtor's) License Rights to Grantee (Secured Party).
Mar 3, 2006
From: PHARMING GROUP N.V.
To: KING GEORGE HOLDINGS LUXEMBOURG IIA S.A.R.L.
Reel/Frame 017240/0737 →
Assignment of Assignor's Interest
Jun 29, 2007
From: ADVANCED CELL TECHNOLOGY, INC.
To: PHARMING GROUP N.V.
Reel/Frame 019501/0043 →
Release of Security Interest
Mar 2, 2010
From: KING GEORGE HOLDINGS LUXEMBOURG IIA S.A.R.L.
To: PHARMING GROUP N.V.
Reel/Frame 024016/0452 →
Security Interest
Dec 7, 2016
From: PHARMING GROUP N.V.
To: SILICON VALLEY BANK
Reel/Frame 040594/0031 →
Amended and Restated Intellectual Property Security Agreement
May 16, 2017
From: PHARMING GROUP N.V.
To: ORBIMED ROYALTY OPPORTUNITIES II, LP
Reel/Frame 042481/0051 →
Release of Security Interest
Jan 28, 2020
From: ORBIMED ROYALTY OPPORTUNITIES II, LP
To: PHARMING GROUP N.V.; PHARMING TECHNOLOGIES B.V.; PHARMING INTELLECTUAL PROPERTY B.V.; BROEKMAN INSTITUUT B.V.
Reel/Frame 051722/0304 →